Michael Link

Clinical Focus

• Hematology/Oncology/Stem Cell Transplant, Pediatric
• Pediatric Hematology-Oncology

Administrative Appointments

• Director, Center for Cancer and Blood Diseases, Lucile Packard Children's Hospital at Stanford , (2002– present )
• Chief, Division of Pediatric Hematology/Oncology, Stanford University School of Medicine , (2000– present )
• Lydia J. Lee Professor in Pediatric Cancer, Stanford University , (2003– present )

Honors and Awards

• Annual Memorial Lectureship, Pediatric Cancer Research Foundation (2004)
• Ben Abelson Memorial Visiting Professor, Washington University School of Medicine (2000)
• Alpha Omega Alpha, Alpha Omega Alpha (1974)
• Phi Beta Kappa, Phi Beta Kappa (1969)

Professional Education

• Board Certification: Pediatric Hematology-Oncology, American Board of Pediatrics (1980)
• Board Certification: General Pediatrics, American Board of Pediatrics (1979)
• Dana-Farber Cancer Institute (1979) MA
• Children's Hospital of Boston (1979) MA
• Children's Hospital of Boston (1976) MA
• Children's Hospital of Boston (1975) MA
• Stanford University School of Medicine (1974) CA
• MD, Stanford University Medicine (1974)
• AB, Columbia College Political Science (1970)

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. 

• Consulting: Saint Jude Childrens Research Hospital

Current Research Interests

Hematology/Oncology, treatment of sarcomas of bone and soft tissue, biology of acute lymphoblastic leukemias, treatment of non-Hodgkin's lymphoma and Hodgkin's disease.

Clinical Trials

• A Phase 2 Open Label Trial of SGN-35 for Systemic Anaplastic Large Cell Lymphoma Recruiting
• Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin's Disease Recruiting
• Reduced Duration Standford V Chemotherapy With Low-Dose Tailored-Field Radiation For Favorable Risk Pediatric Hodgkin Lymphoma Recruiting
• Therapy for Pediatric Hodgkin Lymphoma Recruiting

Publications

• Second Malignant Neoplasms in Survivors of Pediatric Hodgkin's Lymphoma Treated With Low-Dose Radiation and Chemotherapy. O'Brien MM,  Donaldson SS, Balise RR, Whittemore AS, Link MP.  J Clin Oncol.  2010;
• The impact of the privacy rule on cancer research: variations in attitudes and application of regulatory standards. Goss E,  Link MP, Bruinooge SS, Lawrence TS, Tepper JE, Runowicz CD, Schilsky RL.  J Clin Oncol.  2009; 27 (24): 4014-20
• Nodular lymphocyte-predominant Hodgkin lymphoma presenting as fulminant hepatic failure in a pediatric patient: a case report with pathologic, immunophenotypic, and molecular findings. Woolf KM,  Wei MC, Link MP, Arber DA, Warnke RA.  Appl Immunohistochem Mol Morphol.  2008; 16 (2): 196-201
• Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. Donaldson SS,  Link MP, Weinstein HJ, Rai SN, Brain S, Billett AL, Hurwitz CA, Krasin M, Kun LE, Marcus KC, Tarbell NJ, Young JA, Hudson MM.  J Clin Oncol.  2007; 25 (3): 332-7
• Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. Meyers PA,  Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R, Grier H.  J Clin Oncol.  2005; 23 (9): 2004-11
• Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: case report and review of the literature. George TI,  Jeng M, Berquist W, Cherry AM, Link MP, Arber DA.  Pediatr Blood Cancer.  2005; 44 (3): 270-6
• Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study. Miser JS,  Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Grier HE.  J Clin Oncol.  2004; 22 (14): 2873-6
• National Institutes of Health State-of-the-Science Conference Statement: Symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002. Patrick DL,  Ferketich SL, Frame PS, Harris JJ, Hendricks CB, Levin B, Link MP, Lustig C, McLaughlin J, Reid LD, Turrisi AT, Unützer J, Vernon SW.  J Natl Cancer Inst Monogr.  2004; (32): 9-16
• High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma. Crews KR,  Liu T, Rodriguez-Galindo C, Tan M, Meyer WH, Panetta JC, Link MP, Daw NC.  Cancer.  2004; 100 (8): 1724-33
• Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group. Spunt SL,  Smith LM, Ruymann FB, Qualman SJ, Donaldson SS, Rodeberg DA, Anderson JR, Crist WM, Link MP.  Clin Cancer Res.  2004; 10 (18 Pt 1): 6072-9
• High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: results and prognostic indices. Lieskovsky YE,  Donaldson SS, Torres MA, Wong RM, Amylon MD, Link MP, Agarwal R.  J Clin Oncol.  2004; 22 (22): 4532-40
• Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. Hudson MM,  Krasin M, Link MP, Donaldson SS, Billups C, Merchant TE, Kun L, Billet AL, Kaste S, Tarbell NJ, Howard S, Friedmann AM, Hurwitz CA, Young JA, Marcus KC, Rai S, Cowan T, Weinstein HJ.  J Clin Oncol.  2004; 22 (22): 4541-50
• Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy. Smith RS,  Chen Q, Hudson MM, Link MP, Kun L, Weinstein H, Billett A, Marcus KJ, Tarbell NJ, Donaldson SS.  J Clin Oncol.  2003; 21 (10): 2026-33
• National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002. Patrick DL,  Ferketich SL, Frame PS, Harris JJ, Hendricks CB, Levin B, Link MP, Lustig C, McLaughlin J, Ried LD, Turrisi AT, Unützer J, Vernon SW.  J Natl Cancer Inst.  2003; 95 (15): 1110-7
• Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. Goorin AM,  Schwartzentruber DJ, Devidas M, Gebhardt MC, Ayala AG, Harris MB, Helman LJ, Grier HE, Link MP.  J Clin Oncol.  2003; 21 (8): 1574-80
• Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. Grier HE,  Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Miser JS.  N Engl J Med.  2003; 348 (8): 694-701
• Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV. Breneman JC,  Lyden E, Pappo AS, Link MP, Anderson JR, Parham DM, Qualman SJ, Wharam MD, Donaldson SS, Maurer HM, Meyer WH, Baker KS, Paidas CN, Crist WM.  J Clin Oncol.  2003; 21 (1): 78-84
• National action plan for childhood cancer: report of the national summit meetings on childhood cancer. Arceci R,  Ettinger A, Forman E, Haase GM, Hammond GD, Hoffman R, Kupst MJ, Link MP, Lustig CP, Traynor DS.  CA Cancer J Clin.  2002 Nov-Dec; 52 (6): 377-9
• Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: a pediatric oncology group study. Marina NM,  Cochrane D, Harney E, Zomorodi K, Blaney S, Winick N, Bernstein M, Link MP.  Clin Cancer Res.  2002; 8 (2): 413-8
• Assessment of lymphadenopathy in children. Twist CJ,  Link MP.  Pediatr Clin North Am.  2002; 49 (5): 1009-25
• VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial. Donaldson SS,  Hudson MM, Lamborn KR, Link MP, Kun L, Billett AL, Marcus KC, Hurwitz CA, Young JA, Tarbell NJ, Weinstein HJ.  J Clin Oncol.  2002; 20 (14): 3081-7
• Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. Goorin AM,  Harris MB, Bernstein M, Ferguson W, Devidas M, Siegal GP, Gebhardt MC, Schwartz CL, Link M, Grier HE.  J Clin Oncol.  2002; 20 (2): 426-33
• Bone marrow stroma-supported culture of T-lineage acute lymphoblastic leukemic cells predicts treatment outcome in children: a Pediatric Oncology Group study. Winter SS,  Sweatman J, Shuster JJ, Link MP, Amylon MD, Pullen J, Camitta BM, Larson RS.  Leukemia.  2002; 16 (6): 1121-6
• Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation. Friedmann AM,  Hudson MM, Weinstein HJ, Donaldson SS, Kun L, Tarbell NJ, Link MP.  J Clin Oncol.  2002; 20 (14): 3088-94
• Minimax two-stage-designs with applications to tissue banking case-control studies. Shuster J,  Link M, Camitta B, Pullen J, Behm F.  Stat Med.  2002; 21 (17): 2479-93
• Children from ethnic minorities have benefited equally as other children from contemporary therapy for rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. Baker KS,  Anderson JR, Lobe TE, Wharam MD, Qualman SJ, Raney RB, Ruymann FB, Womer RB, Meyer WH, Link MP, Crist WM.  J Clin Oncol.  2002; 20 (22): 4428-33
• Thyroid carcinoma after successful treatment of osteosarcoma: a report of three patients. Verneris M,  McDougall IR, Becton D, Link MP.  J Pediatr Hematol Oncol.  2001 Jun-Jul; 23 (5): 312-5
• Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial. Ferguson WS,  Harris MB, Goorin AM, Gebhardt MC, Link MP, Shochat SJ, Siegal GP, Devidas M, Grier HE.  J Pediatr Hematol Oncol.  2001 Aug-Sep; 23 (6): 340-8
• Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group. Smith LM,  Anderson JR, Qualman SJ, Crist WM, Paidas CN, Teot LA, Pappo AS, Link MP, Grier HE, Wiener ES, Breneman JC, Raney RB, Maurer HM, Donaldson SS.  J Clin Oncol.  2001; 19 (20): 4058-64
• Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. Sandler E,  Lyden E, Ruymann F, Maurer H, Wharam M, Parham D, Link M, Crist W.  Med Pediatr Oncol.  2001; 37 (5): 442-8
• What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? Arndt CA,  Donaldson SS, Anderson JR, Andrassy RJ, Laurie F, Link MP, Raney RB, Maurer HM, Crist WM.  Cancer.  2001; 91 (12): 2454-68
• Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? Wiener ES,  Anderson JR, Ojimba JI, Lobe TE, Paidas C, Andrassy RJ, Raney RB, Qualman SJ, Donaldson SS, Maurer HM, Link MP, Crist WM, Grier HE.  Semin Pediatr Surg.  2001; 10 (3): 146-52
• Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey. Hilden JM,  Emanuel EJ, Fairclough DL, Link MP, Foley KM, Clarridge BC, Schnipper LE, Mayer RJ.  J Clin Oncol.  2001; 19 (1): 205-12
• Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report. Laver JH,  Barredo JC, Amylon M, Schwenn M, Kurtzberg J, Camitta BM, Pullen J, Link MP, Borowitz M, Ravindranath Y, Murphy SB, Shuster J.  Leukemia.  2000; 14 (3): 369-73
• Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. Baker KS,  Anderson JR, Link MP, Grier HE, Qualman SJ, Maurer HM, Breneman JC, Wiener ES, Crist WM.  J Clin Oncol.  2000; 18 (12): 2427-34
• Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons. Hutchison RE,  Finch C, Kepner J, Fuller C, Bowman P, Link M, Schwenn M, Laver J, Desai S, Barrett D, Murphy SB.  Ann Oncol.  2000; 11 Suppl 1 35-8
• New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. Schneider NR,  Carroll AJ, Shuster JJ, Pullen DJ, Link MP, Borowitz MJ, Camitta BM, Katz JA, Amylon MD.  Blood.  2000; 96 (7): 2543-9
• Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Amylon MD,  Shuster J, Pullen J, Berard C, Link MP, Wharam M, Katz J, Yu A, Laver J, Ravindranath Y, Kurtzberg J, Desai S, Camitta B, Murphy SB.  Leukemia.  1999; 13 (3): 335-42
• Treatment of localized primary non-Hodgkin's lymphoma of bone in children: a Pediatric Oncology Group study. Suryanarayan K,  Shuster JJ, Donaldson SS, Hutchison RE, Murphy SB, Link MP.  J Clin Oncol.  1999; 17 (2): 456-9
• Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience. Navid F,  Mosijczuk AD, Head DR, Borowitz MJ, Carroll AJ, Brandt JM, Link MP, Rozans MK, Thomas GA, Schwenn MR, Shields DJ, Vietti TJ, Pullen DJ.  Leukemia.  1999; 13 (1): 135-41
• Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation. Rubnitz JE,  Camitta BM, Mahmoud H, Raimondi SC, Carroll AJ, Borowitz MJ, Shuster JJ, Link MP, Pullen DJ, Downing JR, Behm FG, Pui CH.  J Clin Oncol.  1999; 17 (1): 191-6
• Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study. Pullen J,  Shuster JJ, Link M, Borowitz M, Amylon M, Carroll AJ, Land V, Look AT, McIntyre B, Camitta B.  Leukemia.  1999; 13 (11): 1696-707
• E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): a Pediatric Oncology Group study. Hunger SP,  Fall MZ, Camitta BM, Carroll AJ, Link MP, Lauer SJ, Mahoney DH, Pullen DJ, Shuster JJ, Steuber CP, Cleary ML.  Blood.  1998; 91 (3): 1021-8
• Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study. Harris MB,  Gieser P, Goorin AM, Ayala A, Shochat SJ, Ferguson WS, Holbrook T, Link MP.  J Clin Oncol.  1998; 16 (11): 3641-8
• Randomized trial of r-metHu granulocyte colony-stimulating factor in an intensive treatment for T-cell leukemia and advanced-stage lymphoblastic lymphoma of childhood: a Pediatric Oncology Group pilot study. Laver J,  Amylon M, Desai S, Link M, Schwenn M, Mahmoud H, Shuster J.  J Clin Oncol.  1998; 16 (2): 522-6
• A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group. Donaldson SS,  Torrey M, Link MP, Glicksman A, Gilula L, Laurie F, Manning J, Neff J, Reinus W, Thompson E, Shuster JJ.  Int J Radiat Oncol Biol Phys.  1998; 42 (1): 125-35
• A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the treatment of children with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS) IV pilot study. Arndt C,  Tefft M, Gehan E, Anderson J, Jenson M, Link M, Donaldson S, Breneman J, Wiener E, Webber B, Maurer H.  J Pediatr Hematol Oncol.  1997 Mar-Apr; 19 (2): 124-9
• Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study. Rubnitz JE,  Shuster JJ, Land VJ, Link MP, Pullen DJ, Camitta BM, Pui CH, Downing JR, Behm FG.  Blood.  1997; 89 (4): 1143-6
• Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood. Hutchison RE,  Banki K, Shuster JJ, Barrett D, Dieck C, Berard CW, Murphy SB, Link MP, Pick TE, Laver J, Schwenn M, Mathew P, Morris SW.  Ann Oncol.  1997; 8 Suppl 1 37-42
• Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia. Marks DI,  Kurz BW, Link MP, Ng E, Shuster JJ, Lauer SJ, Carroll D, Brodsky I, Haines DS.  J Clin Oncol.  1997; 15 (3): 1158-62
• Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group. Brecher ML,  Schwenn MR, Coppes MJ, Bowman WP, Link MP, Berard CW, Shuster JJ, Murphy SB.  Med Pediatr Oncol.  1997; 29 (6): 526-33
• Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. Link MP,  Shuster JJ, Donaldson SS, Berard CW, Murphy SB.  N Engl J Med.  1997; 337 (18): 1259-66
• Lack of ETV6 (TEL) gene rearrangements or p16INK4A/p15INK4B homozygous gene deletions in infant acute lymphoblastic leukemia. Maloney KW,  Rubnitz JE, Cleary ML, Frankel LS, Hakami N, Link MP, Pullen DJ, Hunger SP.  Leukemia.  1997; 11 (7): 979-83
• Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Batova A,  Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J, Yu AL.  Cancer Res.  1997; 57 (5): 832-6
• Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. Smith M,  Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reamon G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R.  J Clin Oncol.  1996; 14 (1): 18-24
• Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study. Bowman WP,  Shuster JJ, Cook B, Griffin T, Behm F, Pullen J, Link M, Head D, Carroll A, Berard C, Murphy S.  J Clin Oncol.  1996; 14 (4): 1252-61
• High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis. Marks DI,  Kurz BW, Link MP, Ng E, Shuster JJ, Lauer SJ, Brodsky I, Haines DS.  Blood.  1996; 87 (3): 1155-61
• NCCN pediatric osteosarcoma practice guidelines. The National Comprehensive Cancer Network. O'Reilly R,  Link M, Fletcher B, Gebhardt M, Krance R, Meyers P, Neff J, Schwartz C.  Oncology (Williston Park).  1996; 10 (12): 1799-806, 1812
• Treatment of osteosarcoma with ifosfamide: comparison of response in pediatric patients with recurrent disease versus patients previously untreated: a Pediatric Oncology Group study. Harris MB,  Cantor AB, Goorin AM, Shochat SJ, Ayala AG, Ferguson WS, Holbrook T, Link MP.  Med Pediatr Oncol.  1995; 24 (2): 87-92
• Safety and efficacy of l-leucovorin rescue following high-dose methotrexate for osteosarcoma. Goorin A,  Strother D, Poplack D, Letvak LA, George M, Link M.  Med Pediatr Oncol.  1995; 24 (6): 362-7
• B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: a Pediatric Oncology Group study. Hutchison RE,  Berard CW, Shuster JJ, Link MP, Pick TE, Murphy SB.  J Clin Oncol.  1995; 13 (8): 2023-32
• Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells. Lawrence HJ,  Sauvageau G, Ahmadi N, Lopez AR, LeBeau MM, Link M, Humphries K, Largman C.  Exp Hematol.  1995; 23 (11): 1160-6
• Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study. Rubnitz JE,  Link MP, Shuster JJ, Carroll AJ, Hakami N, Frankel LS, Pullen DJ, Cleary ML.  Blood.  1994; 84 (2): 570-3
• Simultaneous expression of RBTN-2 and BCR-ABL oncogenes in a T-ALL with a t(11;14)(p13;q11) and a late-appearing Philadelphia chromosome. Fizzotti M,  Chen EY, Link MP, Carroll AJ, Foroni L, Rabbitts TH, Crist WM, Clark SS.  Leukemia.  1994; 8 (7): 1124-30
• Hodgkin's disease in the very young. Cleary SF,  Link MP, Donaldson SS.  Int J Radiat Oncol Biol Phys.  1994; 28 (1): 77-83
• Secondary breast cancer in patients presenting with osteosarcoma: possible involvement of germline p53 mutations. Russo CL,  McIntyre J, Goorin AM, Link MP, Gebhardt MC, Friend SH.  Med Pediatr Oncol.  1994; 23 (4): 354-8
• Presenting characteristics of trisomy 8 as the primary cytogenetic abnormality associated with childhood acute lymphoblastic leukemia. A Pediatric Oncology Group (POG) Study (8600/8493). Pettenati MJ,  Rao N, Wofford M, Shuster JJ, Pullen DJ, Ling MP, Steuber CP, Carroll AJ.  Cancer Genet Cytogenet.  1994; 75 (1): 6-10
• ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience. Hunger SP,  Link MP, Donaldson SS.  J Clin Oncol.  1994; 12 (10): 2160-6
• MIC2 analysis in pediatric lymphomas and leukemias. Riopel M,  Dickman PS, Link MP, Perlman EJ.  Hum Pathol.  1994; 25 (4): 396-9
• Ewing's sarcoma--routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study. Perlman EJ,  Dickman PS, Askin FB, Grier HE, Miser JS, Link MP.  Hum Pathol.  1994; 25 (3): 304-7
• Hypnosis in the prevention of chemotherapy-related nausea and vomiting in children: a prospective study. Jacknow DS,  Tschann JM, Link MP, Boyce WT.  J Dev Behav Pediatr.  1994; 15 (4): 258-64
• Osteosarcoma in adolescents and young adults: new developments and controversies. Commentary on the use of presurgical chemotherapy. Link MP,  Cancer Treat Res.  1993; 62 383-5
• Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction. Downing JR,  Head DR, Parham DM, Douglass EC, Hulshof MG, Link MP, Motroni TA, Grier HE, Curcio-Brint AM, Shapiro DN.  Am J Pathol.  1993; 143 (5): 1294-300
• Immunocytochemical study of 12E7 in small round-cell tumours of childhood: an assessment of its sensitivity and specificity. Ramani P,  Rampling D, Link M.  Histopathology.  1993; 23 (6): 557-61
• Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study. Bash RO,  Crist WM, Shuster JJ, Link MP, Amylon M, Pullen J, Carroll AJ, Buchanan GR, Smith RG, Baer R.  Blood.  1993; 81 (8): 2110-7
• HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. Hunger SP,  Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welborn JL, Willman CL, Cleary ML.  Blood.  1993; 81 (12): 3197-203
• Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease. Hudson MM,  Weinstein HJ, Donaldson SS, Greenwald C, Kun L, Tarbell NJ, Humphrey WA, Rupp C, Marina NM, Wilimas J.  J Clin Oncol.  1993; 11 (6): 1080-4
• Langerhans' cell histiocytosis presenting with the superior vena cava syndrome: a case report. Mogul M,  Hartman G, Donaldson S, Gelb A, Link M, Amylon M, Glader B.  Med Pediatr Oncol.  1993; 21 (6): 456-9
• A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias. Morrissey J,  Tkachuk DC, Milatovich A, Francke U, Link M, Cleary ML.  Blood.  1993; 81 (5): 1124-31
• Laboratory-clinical interface. Link MP,  Stevens J, Friend SH, Israel MA, Knudson AG, Sondel PM.  Cancer.  1993; 71 (10 Suppl): 3219-21
• The multi-institutional osteosarcoma study: an update. Link MP,  Cancer Treat Res.  1993; 62 261-7
• t(2;14)(p13;q32): a recurring abnormality in lymphocytic leukemia. A Pediatric Oncology Group study. Watson MS,  Land VJ, Carroll AJ, Pullen J, Borowitz MJ, Link MP, Amylon M, Behm FG.  Cancer Genet Cytogenet.  1992; 58 (2): 121-4
• Osteosarcoma: good news despite crude tools. Simone JV,  Meyer WH, Link MP.  J Clin Oncol.  1992; 10 (1): 1-2
• Intensive sequential chemotherapy for children with acute myelogenous leukemia: VAPA, 80-035, and HI-C-Daze. Grier HE,  Gelber RD, Link MP, Camitta BP, Clavell LA, Weistein HJ.  Leukemia.  1992; 6 Suppl 2 48-51
• Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group. Crist W,  Shuster J, Look T, Borowitz M, Behm F, Bowman P, Frankel L, Pullen J, Krance R, Steuber P.  Leukemia.  1992; 6 Suppl 2 162-6
• Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature. Hunger SP,  Sklar J, Link MP.  J Clin Oncol.  1992; 10 (1): 156-63
• Childhood malignant non-Hodgkin lymphomas of uncommon histology. Ribeiro RC,  Pui CH, Murphy SB, Shuster JJ, Hvizdala EV, Falletta J, Link MP, Sullivan MP, Pick TE, Sandlund JT.  Leukemia.  1992; 6 (8): 761-5
• A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study. Vats T,  Buchanan G, Mehta P, Ragab A, Hvizdale E, Nitschke R, Link M, Beardsley GP, Maybee D, Krischer J.  Invest New Drugs.  1992; 10 (3): 231-4
• Isochromosomes in childhood acute lymphoblastic leukemia: a collaborative study of 83 cases. Pui CH,  Carroll AJ, Raimondi SC, Schell MJ, Head DR, Shuster JJ, Crist WM, Borowitz MJ, Link MP, Behm FG.  Blood.  1992; 79 (9): 2384-91
• Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group study. Abshire TC,  Buchanan GR, Jackson JF, Shuster JJ, Brock B, Head D, Behm F, Crist WM, Link M, Borowitz M.  Leukemia.  1992; 6 (5): 357-62
• Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study. Krischer JP,  Ragab AH, Kun L, Kim TH, Laurent JP, Boyett JM, Cornell CJ, Link M, Luthy AR, Camitta B.  J Neurosurg.  1991; 74 (6): 905-9
• Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study. Goorin AM,  Shuster JJ, Baker A, Horowitz ME, Meyer WH, Link MP.  J Clin Oncol.  1991; 9 (4): 600-5
• Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias. Suryanarayan K,  Hunger SP, Kohler S, Carroll AJ, Crist W, Link MP, Cleary ML.  Blood.  1991; 77 (2): 324-30
• Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings. Diaz PS,  Au D, Smith S, Amylon M, Link M, Smith S, Arvin AM.  Pediatrics.  1991; 87 (2): 166-70
• The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Hunger SP,  Galili N, Carroll AJ, Crist WM, Link MP, Cleary ML.  Blood.  1991; 77 (4): 687-93
• Hodgkin's disease. Treatment of the young child. Donaldson SS,  Link MP.  Pediatr Clin North Am.  1991; 38 (2): 457-73
• Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Link MP,  Goorin AM, Horowitz M, Meyer WH, Belasco J, Baker A, Ayala A, Shuster J.  Clin Orthop Relat Res.  1991; (270): 8-14
• Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Russo C,  Carroll A, Kohler S, Borowitz M, Amylon M, Homans A, Kedar A, Shuster J, Land V, Crist W.  Blood.  1991; 77 (5): 1050-6
• Stage I-II pediatric Hodgkin's disease: long-term follow-up demonstrates equivalent survival rates following different management schemes. Donaldson SS,  Whitaker SJ, Plowman PN, Link MP, Malpas JS.  J Clin Oncol.  1990; 8 (7): 1128-37
• Intensive sequential chemotherapy for children with acute myelogenous leukemia. Grier HE,  Gelber RD, Clavell LA, Camitta BM, Link MP, Garcea MJ, Weinstein HJ.  Haematol Blood Transfus.  1990; 33 193-7
• Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Crist W,  Carroll A, Shuster J, Jackson J, Head D, Borowitz M, Behm F, Link M, Steuber P, Ragab A.  Blood.  1990; 76 (3): 489-94
• Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood. Pui CH,  Carroll AJ, Head D, Raimondi SC, Shuster JJ, Crist WM, Link MP, Borowitz MJ, Behm FG, Land VJ.  Blood.  1990; 76 (3): 590-6
• The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Carroll AJ,  Crist WM, Link MP, Amylon MD, Pullen DJ, Ragab AH, Buchanan GR, Wimmer RS, Vietti TJ.  Blood.  1990; 76 (6): 1220-4
• Down-regulated c-myb expression inhibits DNA synthesis of T-leukemia cells in most patients. Venturelli D,  Mariano MT, Szczylik C, Valtieri M, Lange B, Crist W, Link M, Calabretta B.  Cancer Res.  1990; 50 (22): 7371-5
• Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy. Link MP,  Donaldson SS, Berard CW, Shuster JJ, Murphy SB.  N Engl J Med.  1990; 322 (17): 1169-74
• Small cell osteosarcoma. A clinicopathologic study of 27 cases. Ayala AG,  Ro JY, Raymond AK, Jaffe N, Chawla S, Carrasco H, Link M, Jimenez J, Edeiken J, Wallace S.  Cancer.  1989; 64 (10): 2162-73
• Absence of Ig V region gene somatic hypermutation in advanced Burkitt's lymphoma. Carroll WL,  Yu M, Link MP, Korsmeyer SJ.  J Immunol.  1989; 143 (2): 692-8
• Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy. Donaldson SS,  Link MP, McDougall IR, Parker BR, Shochat SJ.  Cancer Treat Res.  1989; 41 307-15
• Cerebellar atrophy caused by high-dose cytosine arabinoside: CT and MR findings. Miller L,  Link MP, Bologna S, Parker BR.  AJR Am J Roentgenol.  1989; 152 (2): 343-4
• Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy. Mefferd JM,  Donaldson SS, Link MP.  Int J Radiat Oncol Biol Phys.  1989; 16 (3): 679-85
• Cytotoxic T lymphocytes specific for self tumor immunoglobulin express T cell receptor delta chain. Wright A,  Lee JE, Link MP, Smith SD, Carroll W, Levy R, Clayberger C, Krensky AM.  J Exp Med.  1989; 169 (5): 1557-64
• Long-term growth of malignant thymocytes in vitro. Smith SD,  McFall P, Morgan R, Link M, Hecht F, Cleary M, Sklar J.  Blood.  1989; 73 (8): 2182-7
• Aggressive management of second primary tumors in survivors of hereditary retinoblastoma. Smith LM,  Donaldson SS, Egbert PR, Link MP, Bagshaw MA.  Int J Radiat Oncol Biol Phys.  1989; 17 (3): 499-505
• Poor-risk non-lymphoblastic lymphoma of childhood: results of an intensive pilot study. Finlay JL,  Trigg ME, Link MP, Frierdich S.  Med Pediatr Oncol.  1989; 17 (1): 29-38
• Diffuse small noncleaved cell lymphoma in children, Burkitt's versus non-Burkitt's types. Results from the Pediatric Oncology Group and St. Jude Children's Research Hospital. Hutchison RE,  Murphy SB, Fairclough DL, Shuster JJ, Sullivan MP, Link MP, Donaldson SS, Berard CW.  Cancer.  1989; 64 (1): 23-8
• Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34. Smith SD,  Morgan R, Gemmell R, Amylon MD, Link MP, Linker C, Hecht BK, Warnke R, Glader BE, Hecht F.  Blood.  1988; 71 (2): 395-402
• Idiotype as a tumor-specific marker in childhood B cell acute lymphoblastic leukemia. Carroll WL,  Link MP, Cleary ML, Bologna S, Carswell C, Amylon MD, Smith SD, Levy R.  Blood.  1988; 71 (4): 1068-73
• Treatment of osteosarcoma. Link MP,  Lancet.  1988; 1 (8598): 1334
• Philadelphia chromosome-positive acute lymphoblastic leukemia cell lines without classical breakpoint cluster region rearrangement. Naumovski L,  Morgan R, Hecht F, Link MP, Glader BE, Smith SD.  Cancer Res.  1988; 48 (10): 2876-9
• Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia. Bird J,  Galili N, Link M, Stites D, Sklar J.  J Exp Med.  1988; 168 (1): 229-45
• Postremission induction intensive sequential chemotherapy for children with AML--treatment results and prognostic factors. Weinstein H,  Grier H, Gelber R, Camitta B, Link M, Delorey M, Price K.  Haematol Blood Transfus.  1987; 30 88-92
• Establishment and characterization of a common acute lymphoblastic leukemia cell line with a deletion of chromosome 3 band q26. Smith SD,  Morgan R, Galili N, Amylon MD, Link MP, Hecht F, Sklar J, Glader BE.  Cancer Res.  1987; 47 (6): 1652-6
• Improved results of treatment of adult acute lymphoblastic leukemia. Linker CA,  Levitt LJ, O'Donnell M, Ries CA, Link MP, Forman SJ, Farbstein MJ.  Blood.  1987; 69 (4): 1242-8
• Absence of cell surface LFA-1 as a mechanism of escape from immunosurveillance. Clayberger C,  Wright A, Medeiros LJ, Koller TD, Link MP, Smith SD, Warnke RA, Krensky AM.  Lancet.  1987; 2 (8558): 533-6
• Quantitation and estimation of lymphocyte subsets in tissue sections. Comparison with flow cytometry. Garcia CF,  Weiss LM, Lowder J, Komoroske C, Link MP, Levy R, Warnke RA.  Am J Clin Pathol.  1987; 87 (4): 470-7
• Prognostic factors in childhood acute myelogenous leukemia. Grier HE,  Gelber RD, Camitta BM, Delorey MJ, Link MP, Price KN, Leavitt PR, Weinstein HJ.  J Clin Oncol.  1987; 5 (7): 1026-32
• Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. Donaldson SS,  Link MP.  J Clin Oncol.  1987; 5 (5): 742-9
• Giant cell pneumonia caused by parainfluenza type 3 in a patient with acute myelomonocytic leukemia. Weintrub PS,  Sullender WM, Lombard C, Link MP, Arvin A.  Arch Pathol Lab Med.  1987; 111 (6): 569-70
• Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana-Farber Cancer Institute/the Children's Hospital--study III. Goorin AM,  Perez-Atayde A, Gebhardt M, Andersen JW, Wilkinson RH, Delorey MJ, Watts H, Link M, Jaffe N, Frei E.  J Clin Oncol.  1987; 5 (8): 1178-84
• Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Weiss LM,  Bindl JM, Picozzi VJ, Link MP, Warnke RA.  Blood.  1986; 67 (2): 474-8
• Adjuvant therapy in the treatment of osteosarcoma. Link MP,  Important Adv Oncol.  1986; 193-207
• Chronic infectious mononucleosis syndrome, pancytopenia, and polyclonal B-lymphoproliferation terminating in acute lymphoblastic leukemia. Finlay J,  Luft B, Yousem S, Wood GS, Link M, Arvin A, Glader B, Lennette E, Shatsky M, Olds L.  Am J Pediatr Hematol Oncol.  1986; 8 (1): 18-27
• A unique antigen on mature B cells defined by a monoclonal antibody. Link MP,  Bindl J, Meeker TC, Carswell C, Doss CA, Warnke RA, Levy R.  J Immunol.  1986; 137 (9): 3013-8
• Common mechanism of chromosome inversion in B- and T-cell tumors: relevance to lymphoid development. Denny CT,  Hollis GF, Hecht F, Morgan R, Link MP, Smith SD, Kirsch IR.  Science.  1986; 234 (4773): 197-200
• Chromosome 9 abnormalities in childhood T-cell leukemia. Smith SD,  Link MP, Trela M, Amylon M, Sklar J, Morgan R, Hecht F.  N Engl J Med.  1986; 315 (3): 195-6
• The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. Link MP,  Goorin AM, Miser AW, Green AA, Pratt CB, Belasco JB, Pritchard J, Malpas JS, Baker AR, Kirkpatrick JA.  N Engl J Med.  1986; 314 (25): 1600-6
• Chromosome clues to acute leukemia in Down's syndrome. Hecht F,  Hecht BK, Morgan R, Sandberg AA, Link MP.  Cancer Genet Cytogenet.  1986; 21 (2): 93-8
• Cytogenetic and immunophenotypic analysis of cell lines established from patients with T cell leukemia/lymphoma. Smith SD,  Morgan R, Link MP, McFall P, Hecht F.  Blood.  1986; 67 (3): 650-6
• Mediastinal nonlymphoblastic lymphomas in children: a clinicopathologic study. Bunin NJ,  Hvizdala E, Link M, Callihan TR, Hustu HO, Wharam M, Warnke RA, Berard CW, Murphy SB.  J Clin Oncol.  1986; 4 (2): 154-9
• Leukemia with Down's syndrome: translocation between chromosomes 1 and 19 in acute myelomonocytic leukemia following transient congenital myeloproliferative syndrome. Morgan R,  Hecht F, Cleary ML, Sklar J, Link MP.  Blood.  1985; 66 (6): 1466-8
• Discordance between surface and cytoplasmic expression of the Leu-4 (T3) antigen in thymocytes and in blast cells from childhood T lymphoblastic malignancies. Link MP,  Stewart SJ, Warnke RA, Levy R.  J Clin Invest.  1985; 76 (1): 248-53
• Abnormal helper:suppressor T-cell ratio in the staff of a pediatric hospital. Somma C,  Miller JJ, Silverman ED, Link MP.  N Engl J Med.  1985; 312 (24): 1573-4
• Non-Hodgkin's lymphoma in children. Link MP,  Pediatr Clin North Am.  1985; 32 (3): 699-720
• Acute leukemias associated with the 4;11 chromosome translocation have rearranged immunoglobulin heavy chain genes. Crist WM,  Cleary ML, Grossi CE, Prasthofer EF, Heggie GD, Omura GA, Carroll AJ, Link MP, Sklar J.  Blood.  1985; 66 (1): 33-8
• Conservative management of testicular endodermal sinus tumor in childhood. Carroll WL,  Kempson RL, Govan DE, Freiha FS, Shochat SJ, Link MP.  J Urol.  1985; 133 (6): 1011-4
• Immunologic selection of hemopoietic precursor cells utilizing antibody-mediated plate binding ("panning"). Greenberg PL,  Baker S, Link M, Minowada J.  Blood.  1985; 65 (1): 190-7
• A unique human B lymphocyte antigen defined by a monoclonal antibody. Meeker TC,  Miller RA, Link MP, Bindl J, Warnke R, Levy R.  Hybridoma.  1984; 3 (4): 305-20
• Pan-leukocyte monoclonal antibody L3B12. Characterization and application to research and diagnostic problems. Wood GS,  Link M, Warnke RA, Dilley J, Levy R.  Am J Clin Pathol.  1984; 81 (2): 176-83
• Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Constine LS,  Donaldson SS, McDougall IR, Cox RS, Link MP, Kaplan HS.  Cancer.  1984; 53 (4): 878-83
• Acute nonlymphocytic leukemia developing during the course of Ewing's sarcoma. Link MP,  Donaldson SS, Kempson RL, Wilbur JR, Glader BE.  Med Pediatr Oncol.  1984; 12 (3): 194-200
• Immune thrombocytopenia associated with acute nonlymphocytic leukemia. Amylon MD,  Link MP, Glader BE.  J Pediatr.  1984; 105 (5): 776-8
• Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: analysis of 32 patients. Goorin AM,  Delorey MJ, Lack EE, Gelber RD, Price K, Cassady JR, Levey R, Tapper D, Jaffe N, Link M.  J Clin Oncol.  1984; 2 (5): 425-31
• Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. Smith SD,  Shatsky M, Cohen PS, Warnke R, Link MP, Glader BE.  Cancer Res.  1984; 44 (12 Pt 1): 5657-60
• Cutaneous lymphoblastic lymphoma with pre-B markers. Link MP,  Roper M, Dorfman RF, Crist WM, Cooper MD, Levy R.  Blood.  1983; 61 (5): 838-41
• Cranial nerve involvement in children with leukemia and lymphoma. Paryani SB,  Donaldson SS, Amylon MD, Link MP.  J Clin Oncol.  1983; 1 (9): 542-5
• Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine. Abelson HT,  Fosburg MT, Beardsley GP, Goorin AM, Gorka C, Link M, Link D.  J Clin Oncol.  1983; 1 (3): 208-16
• Identification and significance of cell markers in leukemia and lymphoma. Warnke RA,  Link MP.  Annu Rev Med.  1983; 34 117-31
• A single monoclonal antibody identifies T-cell lineage of childhood lymphoid malignancies. Link M,  Warnke R, Finlay J, Amylon M, Miller R, Dilley J, Levy R.  Blood.  1983; 62 (4): 722-8
• High-dose methotrexate in osteogenic sarcoma adjuvant chemotherapy and limb salvage results. Jaffe N,  Goorin A, Link M, Watts H, Frei E, Vawter G, Fellows KE, Beardsley GP, Abelson HT.  Cancer Treat Rep.  1981; 65 Suppl 1 99-106
• High-dose methotrexate in osteogenic sarcoma. Jaffe N,  Link MP, Cohen D, Traggis D, Frei E, Watts H, Beardsley GP, Abelson HT.  Natl Cancer Inst Monogr.  1981; (56): 201-6
• Fetal-like erythropoiesis during recovery from transient erythroblastopenia of childhood (TEC). Link MP,  Alter BP.  Pediatr Res.  1981; 15 (7): 1036-9
• Non-Hodgkin's lymphoma in childhood. Weinstein HJ,  Link MP.  Clin Haematol.  1979; 8 (3): 699-716